|
Q3 FY2026
As of Aug 31, 2026
|
Q2 FY2026
As of May 31, 2026
|
Q1 FY2026
As of Feb 28, 2026
|
Q4 FY2025
As of Nov 30, 2025
|
Q3 FY2025
As of Aug 31, 2025
|
Q2 FY2025
As of May 31, 2025
|
Q1 FY2025
As of Feb 28, 2025
|
Q4 FY2024
As of Nov 30, 2024
|
Q3 FY2024
As of Aug 31, 2024
|
Q2 FY2024
As of May 31, 2024
|
Q1 FY2024
As of Feb 29, 2024
|
Q4 FY2023
As of Nov 30, 2023
|
Q3 FY2023
As of Aug 31, 2023
|
Q2 FY2023
As of May 31, 2023
|
Q1 FY2023
As of Feb 28, 2023
|
Q4 FY2022
As of Nov 30, 2022
|
Q3 FY2022
As of Aug 31, 2022
|
Q2 FY2022
As of May 31, 2022
|
Q1 FY2022
As of Feb 28, 2022
|
Q4 FY2021
As of Nov 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable (net of allowance for doubtful accounts of $4,366,902 and $4,306,410, respectively) | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Inventory, current portion | ||||||||||||||||||||
| Swap contract | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and Equipment-net | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Investment | ||||||||||||||||||||
| Duke license agreement, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Inventory, net of current portion | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Deposits and other assets, net | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Note payable | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Current portion of operating lease liability | ||||||||||||||||||||
| Duke license agreement liability | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Deferred revenue, net of current portion | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Note payable, net of current portion and debt issuance costs | ||||||||||||||||||||
| Operating lease long-term liability | ||||||||||||||||||||
| Long-term liability - revenue sharing agreements | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies (Note 9) | ||||||||||||||||||||
| Stockholders' Deficit | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Series A Junior Participating Preferred Stock | ||||||||||||||||||||
| Total preferred stock | ||||||||||||||||||||
| Common stock ($.01 par value, 20,000,000 authorized; 14,884,619 issued and 8,062,650 outstanding as of August 31, 2026 and 14,877,119 issued and 8,055,150 outstanding as of November 30, 2025) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...
